Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | LPL | P06858 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
| ▸ | DRD5 | P21918 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1775603 | 0.90 | SKP2 (0.38) | CNR1CNR2LPLLIPGCA2 | |
| SCHEMBL3667864 | 0.89 | CNR1 (0.39) | CNR1CNR2LPLLIPGALOX5 | |
| SCHEMBL1776797 | 0.89 | TRPA1 (0.34) | CNR1CNR2 | |
| SCHEMBL15610595 | 0.88 | LPL (0.38) | CNR1CNR2LPLLIPG | |
| SCHEMBL1776240 | 0.87 | LPL (0.39) | LPLLIPG | |
| SCHEMBL27730399 | 0.86 | LOX (0.34) | — | |
| SCHEMBL677715 | 0.83 | SKP2 (0.43) | LPLLIPGCA2 | |
| SCHEMBL1778991 | 0.83 | CNR1 (0.35) | CNR1CNR2 | |
| SCHEMBL677464 | 0.82 | PTGS2 (0.42) | LPLLIPG | |
| SCHEMBL1778966 | 0.80 | PTGS2 (0.44) | LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-07-04 | — | — | US | claimed |
| WO-2023196594-A2 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-10-12 | — | — | WO | claimed |
| US-10441946-B2 | Linear alpha-olefin catalysts and preparation and use thereof | APALENE TECHNOLOGY CO., LTD. (HANGZHOU) (CN) | 2019-10-15 | — | — | US | claimed |
| CN-105797773-B | Novel linear alhpa olefin catalyst and its preparation process and purposes | 亚培烯科技（杭州）有限公司 | 2018-11-06 | — | — | CN | claimed |
| US-20180147571-A1 | NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF | APALENE TECHNOLOGY CO., LTD. (JIAXING) (CN) | 2018-05-31 | — | — | US | claimed |
| CN-105797774-B | Novel linear alhpa olefin catalyst and its preparation and commercial Application | 亚培烯科技(嘉兴)有限公司 | 2018-03-13 | — | — | CN | claimed |
| CN-105728045-B | Novel linear alhpa olefin catalyst and its preparation method and application | 亚培烯科技(嘉兴)有限公司 | 2017-09-22 | — | — | CN | claimed |
| CN-105797773-A | Novel linear alpha-olefin catalyst and preparation technology and application thereof | 亚培烯科技(嘉兴)有限公司 | 2016-07-27 | — | — | CN | claimed |
| CN-105797774-A | Novel linear alpha-olefin catalyst and preparation and industrial application thereof | 亚培烯科技(嘉兴)有限公司 | 2016-07-27 | — | — | CN | claimed |
| CN-105728045-A | Novel linear alpha olefin catalyst and preparation method and application thereof | 亚培烯科技(嘉兴)有限公司 | 2016-07-06 | — | — | CN | claimed |
| CN-103894230-B | Preparation and application of supported iron catalyst | PETROCHINA COMPANY LIMITED (CN) | 2016-04-06 | — | — | CN | claimed |
| CN-103894230-A | Preparation and application of supported iron catalyst | PETROCHINA CO LTD | 2014-07-02 | — | — | CN | claimed |
| CN-102432415-B | Preparation method of ethylene-propylene copolymer | CHINESE ACAD INST CHEMISTRY | 2013-12-04 | — | — | CN | claimed |
| CN-100512962-C | Binuclear iron-based catalyst composition for preparing alpha-olefin by ethylene oligomerization and application thereof | PETROCHINA CO LTD (CN) | 2009-07-15 | — | — | CN | claimed |
| CN-1247492-C | Cobalt catalyst composition for ethylene oligomerization and application thereof | CHINA NAT PETROLEUM CORP (CN) | 2006-03-29 | — | — | CN | claimed |
| CN-1202049-C | Iron-based catalyst composition for ethylene oligomerization and application thereof | CHINA NAT PETROLEUM CORP (CN) | 2005-05-18 | — | — | CN | claimed |
| CN-1463799-A | Binuclear iron-based catalyst composition for preparing alpha-olefin by ethylene oligomerization and method for preparing linear alpha-olefin | PETROCHINA CO LTD (CN) | 2003-12-31 | — | — | CN | claimed |
| CN-1463800-A | Binuclear cobalt catalyst composition for synthesizing linear alpha-olefin by ethylene oligomerization and method for preparing linear alpha-olefin | PETROCHINA CO LTD (CN) | 2003-12-31 | — | — | CN | claimed |
| CN-1403424-A | Cobalt catalyst composition for ethylene oligomerization and preparation method of alpha-olefin | CHINA NAT PETROLEUM CORP (CN) | 2003-03-19 | — | — | CN | claimed |
| CN-1374281-A | Iron-based catalyst composition for ethylene oligomerization and preparation method of alpha-olefin | CHINA PETROLEUM CORP (CN) | 2002-10-16 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180147571-A1 | NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF | UBE2L3, RNF168, AGL | CNR1 3394/4885CNR2 3801/4885LPL 4190/4885 |
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | FABP7, FFAR1, FABP1 | CNR1 572/4885CNR2 1058/4885LPL 804/4885 |
| US-10441946-B2 | Linear alpha-olefin catalysts and preparation and use thereof | UBE2L3, COG8, ACSL3 | CNR1 3606/4885CNR2 3896/4885LPL 4176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.